Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype

Contributors and Hemochromatosis International Taskforce

Research output: Contribution to journalEditorial

45 Scopus citations

Abstract

Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.

Original languageEnglish
Pages (from-to)83-86
Number of pages4
JournalHepatology International
Volume12
Issue number2
DOIs
StatePublished - 1 Mar 2018

Bibliographical note

Publisher Copyright:
© 2018, The Author(s).

Fingerprint

Dive into the research topics of 'Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype'. Together they form a unique fingerprint.

Cite this